Gut hormone GIP may calm nausea by boosting blood flow to the abdomen
NCT ID NCT07687589
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study tests whether the gut hormone GIP can reduce nausea in healthy volunteers. Nausea is triggered using other gut hormones or a medication, and GIP is given intravenously to see if it lessens the sick feeling. The goal is to better understand how the gut and brain communicate to control nausea.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Glucose-dependent Insulinotropic Polypeptide (GIP)
- What this could lead to
- If GIP reduces nausea, it could point toward a new treatment for nausea without strong side effects.
- What could go wrong
- This is a small, early study in healthy people, so results may not apply to patients with chronic nausea. The effect may be weak or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EMESIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Center for Clinical Metabolic Research, Herlev-Gentofte Hospital
Hellerup, 2900, Denmark